Electronic Medical Record-Embedded Clinical Decision Support System for Opioid Prescribing Shows Mixed Outcomes

Published Mar 4, 2020

Results Include Increase in Urine Drug Screens and Naloxone Prescriptions, But No Change in Rate of Prescribing High-Dose Opioids

Value in HealthLawrenceville, NJ, USA—March 4, 2020—Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of new research showing mixed clinical results of an electronic medical record (EMR)-embedded clinical decision support system for opioid prescribing. The report, “Clinical Effectiveness of Decision Support for Prescribing Opioids for Chronic Noncancer Pain: A Prospective Cohort Study,” was published in the February 2020 issue of Value in Health

To promote patient safety, quality of care, and adherence to practice guidelines for safely prescribing opioids for chronic noncancer pain in the United States, Ochsner Health System implemented a multicomponent electronic medical record clinical decision support (EMR CDS) system in accordance with the 2016 US Centers for Disease Control and Prevention guideline. The EMR CDS directly targeted providers to increase awareness of best practices within their usual workflow. It incorporated an opioid health maintenance tool to display the status of risk mitigation, and the medication order embedded the morphine equivalent daily dose calculator and a hyperlink to the Louisiana pharmacy drug monitoring program.

After incorporation of the EMR CDS system, patients had higher rates of urine drug screens and naloxone prescriptions. In addition, specialty referrals to physical or occupational therapy, orthopedics, neurology, and psychiatry or psychology increased in the postintervention period. Although emergency department use decreased, hospitalization rates did not change. Furthermore, implementation of the EMR CDS did not change the main outcome of interest, namely, rates of prescribing high-dose opioids.

“Given the nationwide opioid crisis, health systems and providers must urgently find ways to extend opioid management beyond standardized monitoring of risk factors for misuse or abuse and set clear protocols for next steps in chronic care management,” said author Eboni G. Price-Haywood, MD, MPH, director, Center for Outcomes and Health Services Research, Ochsner Health System, New Orleans, LA, USA. “In this article, we show that technology optimization targeting providers may improve some aspects of opioid risk mitigation but may not as a single intervention change opioid-prescribing behaviors. Multilevel interventions that concurrently target patients, providers, health systems, and health policy are likely to be more effective.”


ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website  | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram

Value in Health (ISSN 1098-3015) is an international, indexed journal that publishes original research and health policy articles that advance the field of health economics and outcomes research to help healthcare leaders make evidence-based decisions. The journal’s 2018 impact factor score is 5.037. Value in Health is ranked 5th of 98 journals in healthcare sciences and services, 4th of 81 journals in health policy and services, and 11th of 363 journals in economics. Value in Health is a monthly publication that circulates to more than 10,000 readers around the world.
Website  | Twitter (@isporjournals)

Related Stories

Patient-Reported Experience Measures Indicate How Well Healthcare Systems Meet the Needs of Patients

Jan 10, 2023

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research—announced the publication of a series of articles that promotes an understanding of patient-reported experience measures and their role in healthcare. The series was published in the January 2023 issue of Value in Health.

Global Expert Panel Publishes New Guidance on Designing and Conducting Real-World Evidence Studies

Oct 11, 2022

Value in Health, the official journal of ISPOR, announced the publication of a new template that provides a set of core recommendations for clear and reproducible real-world evidence study protocols.

Multinational Health Panel Challenges Recent Change in How Drug Benefit Is Measured in Germany

Aug 31, 2022

Value in Health announced the publication of a new report from the ISPOR Clinical Outcome Assessment Special Interest Group that cautioned the universal applicability of a recent change by German health technology assessment organization, IQWiG, (Institute for Quality and Efficiency in Health Care), regarding the process of assessing the added benefit of drug interventions.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now